← SynDRA
MILNACIPRAN
SynDRA canonical compound SYN0008898 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | SLC6A4 |
|---|
| Mechanism of action | Serotonin reuptake inhibitor |
|---|
| Indication | fibromyalgia |
|---|
| Disease area | rheumatology |
|---|
All known targets
- SLC6A2
- SLC6A4
- SLC6A3
- GRIN2A
- NET
- Slc6a3
- Slc6a4
Mechanisms of action (all sources)
- Serotonin reuptake inhibitor
- SLC6A3 INHIBITOR
- SLC6A2 INHIBITOR
- SLC6A4 INHIBITOR
- serotonin–norepinephrine reuptake inhibitor (SNRI)
- serotoninânorepinephrine reuptake inhibitor (snri)
Drug classes
- Norepinephrine Uptake Inhibitors
- Serotonin Uptake Inhibitors
- Analgesics
- Analgesics, Non-Narcotic
- Central Nervous System Agents
- Membrane Transport Modulators
- Neurotransmitter Agents
- Neurotransmitter Uptake Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
- Serotonin and Noradrenaline Reuptake Inhibitors
- Serotonin and Norepinephrine Reuptake Inhibitor
ATC classes
Cross-references
Synonyms
- midalcipran
- (+/-)-Milnacipran
- milnacipran hydrochloride
- milnacipran HCl
- Impulsor
- Milnacipran pierre fabre medicament
- (+-)-Milnacipran
- L-Milnacipran Hydrochloride
- SCHEMBL114034
- GTPL7436
- CHEBI:135005
- BDBM50490618
- EBC-26308
- AKOS026750554
- TS-08444
- DS-015843
- AB01563301_01
- EN300-26869031
- BRD-A15202882-003-02-7
- 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane
- Milnacipran hydrochloride
- AKOS025401404
- HMS5085I13
- Savella
- NSC-759806
- Pharmakon1600-01504815
- Milnacipran hcl
- LS-14442
- SCHEMBL1156056
- Dalcipran
- Toledomin
- Y10009
- NSC759806
- AKOS026750053
- CCG-213316
- Ixel
- MFCD01735755
- HMS5081O18
Look up MILNACIPRAN in the interactive SynDRA portal →